Microparticles in Scuba Divers With Decompression Sickness



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:August 2011
End Date:August 2016
Contact:Stephen R Thom, MD, PhD
Email:sthom@mail.med.upenn.edu
Phone:215-898-9102

Use our guide to learn which trials are right for you!

Phase 1 Study Investigating Alterations of Circulating Microparticles in Scuba Divers With Decompression Sickness

The investigators hypothesize that membrane microparticles (MPs) are liberated into the
blood stream in response to decompression stress and that certain MPs characteristics
initiate inflammatory responses that contribute to the clinical syndrome the investigators
call decompression sickness. The research goal is to evaluate the number, type and
time-course for elevations in MPs in sport SCUBA divers who present for treatment of
decompression sickness. Blood samples are to be taken from consenting patients before and
after they undergo treatment for decompression sickness and at a follow-up clinic visit from
1 to 3 weeks later (three samples total).

Microparticles (MPs) are small membrane bound vesicles shed from the surface of a variety of
cells by what appear to be well regulated processes. They are elevated in many physiological
and disease states and in some instances have been associated with organ injury. Shear
stress - as can be caused by intravascular bubbles - is one of the stimuli known to cause
cells to release microparticles. Most sport SCUBA dives have been shown to generate
intravascular bubbles - even safe dives well within limits established by the US Navy and
sports authorities. The investigators have reported elevations in several sub-types of MPs
in a group of individuals undergoing a well monitored series of open-water SCUBA dives.
There is no information of the occurrence of MPs in injured divers. The investigators have
published results using a murine model which demonstrated that mice subjected to varying
decompression stresses exhibit progressive elevations in circulating MPs derived from
leukocytes, erythrocytes, platelets and endothelial cells. Using novel interventions the
investigators demonstrated that MPs cause intravascular neutrophil activation and
inflammatory perivascular injuries. Therefore, there is pathophysiological information to
suggest that one or more element of MPs (number and/or pro-inflammatory subtype) may be
proximal elements that precipitate the clinical syndrome the investigators call
decompression sickness.

Inclusion Criteria:

- Patients who are given the diagnosis of decompression sickness will be offered entry
into this study

Exclusion Criteria:

- Inability to provide informed consent
We found this trial at
1
site
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Principal Investigator: Stephen R Thom, MD,PhD
Phone: 215-898-9102
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials